Women With PMOS Should Get Yearly NHS Checks, Says NICE
It took Sharon Manship more than ten years to get a diagnosis for a condition that affects roughly one in eight women. New NHS guidance aims to stop that wait happening to the next generation.
Draft guidance from health regulator NICE recommends annual checks for women with polyendocrine metabolic ovarian syndrome, or PMOS — the condition long known as polycystic ovary syndrome (PCOS) before its name change earlier this year.
A Renamed, Still Under-Diagnosed Condition
PMOS was renamed in May to better reflect the condition's broad impact across the body, not just the reproductive system. Despite an estimated three to four million women in the UK living with it, NICE says PMOS remains under-diagnosed and inconsistently managed.
"It was so disheartening to be told, until I was finally diagnosed in my mid-30s, that my symptoms were just part of being a woman," said Manship, who sat on the NICE committee that developed the new guideline after living with the condition for 30 years.
📰 Read Also: Millions Take Calcium and Vitamin D for Bone Health. A Major Review Finds Limited Benefit
What the Annual Check Would Cover
The draft guidance urges faster diagnosis alongside more consistent monitoring, recommending the new checks cover not just core symptoms — irregular periods, excessive hair growth, weight gain — but longer-term risks including diabetes and heart disease. NICE says lifestyle changes alongside existing treatment could help prevent more serious illness down the line.
Notably, the guidance says laser and light therapy for hair reduction should not be recommended on the NHS due to cost, even though excess hair growth is a common symptom.
📰 Read Also: GLP-1 Drugs May Boost Male Fertility, New Study Finds
Who's Most Affected
NICE says PMOS is thought to be more common in women of Black, Asian, and mixed ethnicity, and it wants healthcare professionals to factor that into how they assess symptoms. The guidance is also explicit that PMOS should not be ruled out in women who have already been through menopause — a group sometimes overlooked in current care pathways.
Mental health is part of the picture too. The draft guidelines note that depression and anxiety are common among women living with PMOS, and recommend that anyone planning a pregnancy receive advice covering weight, diet, nutrition, exercise, sleep, and mental health together, rather than addressing physical symptoms in isolation.
📰 Read Also: Researchers Are Uncovering ADHD's Deep Links to Heart Disease, Sleep Disorders and Obesity
No Cure, But a Clearer Pathway
There remains no cure for PMOS, but the NHS already offers treatments to manage symptoms, including hormone support and fertility drugs. Marie Anne Ledingham, NICE's consultant clinical advisor for women's and reproductive health, called the recommended annual review a "simple" but "important step."
"This new guideline will help improve consistency of care, increase awareness of the condition, and support earlier diagnosis and management," Ledingham said.
The draft guideline is open for public consultation from July 1 to August 11, with NICE inviting feedback from healthcare professionals, patients, and the public. A final guideline is expected in December.
TL;DR
- NICE draft guidance recommends yearly NHS checks for women with PMOS (formerly PCOS)
- The condition affects an estimated one in eight women but remains under-diagnosed
- Annual checks would monitor diabetes and heart disease risk, not just core symptoms
- PMOS is more common in women of Black, Asian, and mixed ethnicity, NICE says
- Public consultation runs July 1 to August 11; final guidance expected in December
